Check out our most popular compounded medications! Get Started
Morphine Sulfate 120 mg Slow Release Capsules are compounded with Methocel E4M, a controlled-release polymer. This formulation is designed to gradually release the active ingredient over an extended period, providing sustained therapeutic effects. This reduces the need for frequent dosing and improves patient compliance. These capsules are used for the management of chronic, cancer, postoperative, neuropathic, and arthritis pain.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Morphine Sulfate 120 mg Slow Release Capsules are a potent, long-acting opioid analgesic designed to manage moderate to severe pain. This formulation is specifically engineered to provide a steady, consistent release of the active ingredient, Morphine Sulfate, over an extended period of time.
The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This polymer is designed to gradually release the encapsulated medication over time, offering sustained therapeutic effects. This reduces the need for frequent dosing and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
However, this formulation is not recommended for patients dealing with acute pain, as it may not provide immediate or adequate pain relief. It's also important for patients to be aware that Morphine Sulfate 120 mg Slow Release Capsules may cause side effects such as drowsiness, dizziness, and confusion. As such, patients should avoid driving or operating machinery while taking this medication.
Additionally, patients should be aware that this medication can be habit-forming and should only be taken as prescribed. Overuse or misuse can lead to dependency or addiction. Therefore, it's crucial to follow the prescribed dosage and duration of treatment.
For healthcare providers, it's important to note that Morphine Sulfate 120 mg Slow Release Capsules can cause respiratory depression. Therefore, it should be used with caution in patients with respiratory conditions. As with patients, healthcare providers should also be aware of the potential for habit-forming tendencies and should prescribe this medication for the shortest duration possible to achieve the desired therapeutic effect.
If you have any questions or concerns about Morphine Sulfate 120 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. We are here to provide you with the information and support you need to ensure safe and appropriate use of this medication.
Morphine Sulfate 120 mg Slow Release Capsules are a potent analgesic formulation designed for the management of moderate to severe pain. These capsules are uniquely formulated with Methocel E4M, a type of controlled-release polymer. This innovative technology allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism not only enhances the efficacy of the medication but also reduces the frequency of dosing, thereby improving patient compliance.
It is crucial to note that this formulation is contraindicated in patients with known hypersensitivity to morphine or other opioids, as well as in patients with significant respiratory depression. Close monitoring is required for signs of respiratory depression, sedation, and hypotension. Additionally, vigilance is necessary for signs of opioid abuse or misuse, which may manifest as euphoria, confusion, or hallucinations.
Patients are strongly advised to abstain from alcohol and other CNS depressants while on this medication. Activities requiring mental alertness, such as driving or operating machinery, should be avoided until the patient is fully aware of how this medication affects them. In the event of any signs of an allergic reaction, such as rash, hives, or difficulty breathing, patients should immediately seek medical attention.
It is our commitment to provide comprehensive information to ensure the safe and appropriate use of Morphine Sulfate 120 mg Slow Release Capsules. If you have any questions or concerns, please do not hesitate to reach out.
Morphine Sulfate 120 mg Slow Release Capsules are a potent, extended-release analgesic formulation designed to manage moderate to severe pain. These capsules are formulated with Methocel E4M, a type of controlled-release polymer, which ensures the gradual release of the encapsulated medication over an extended period. This slow-release mechanism provides a sustained therapeutic effect, reducing the need for frequent dosing and enhancing patient compliance, particularly for those requiring a controlled and prolonged release profile.
The capsules are administered orally, typically once a day, and should be consumed with food to enhance absorption. It is crucial to adhere to the prescribed dosage and frequency as directed by your healthcare provider. Overdosing or underdosing, as well as taking the medication more frequently than advised, can lead to undesirable effects or reduced efficacy.
Morphine Sulfate 120 mg Slow Release Capsules are versatile in their application, providing relief from various types of pain including cancer-related pain, post-operative discomfort, chronic pain conditions, and pain associated with end-stage renal disease. The medication functions by inhibiting pain signals from reaching the brain.
Like all medications, Morphine Sulfate 120 mg Slow Release Capsules may cause side effects such as nausea, constipation, dizziness, and drowsiness. It is essential to communicate any side effects experienced to your healthcare provider. Additionally, inform your doctor of any allergies or existing medical conditions that could potentially interact with this medication.
If you have any queries or concerns regarding Morphine Sulfate 120 mg Slow Release Capsules, please do not hesitate to reach out to your healthcare provider or pharmacist. They can provide comprehensive information about how this medication works and how it can assist in managing your pain effectively.
Morphine Sulfate 120 mg Slow Release Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to release the encapsulated medication gradually over an extended period of time.
The controlled-release polymer, Methocel E4M, is designed to offer sustained therapeutic effects, reduce dosing frequency, and improve patient compliance for medications requiring a controlled and prolonged release profile.
The slow release of the medication provides a steady and prolonged therapeutic effect. This reduces the need for frequent dosing and improves patient compliance, as they are less likely to miss doses.
Methocel E4M is a type of controlled-release polymer used in the formulation of certain medications. It is designed to gradually release the active ingredient over an extended period of time.
The dosing frequency of Morphine Sulfate 120 mg Slow Release Capsules will depend on your doctor's prescription. The slow-release formulation is designed to reduce the need for frequent dosing.
No, breaking or crushing the capsules can interfere with the controlled-release mechanism and may lead to a rapid release and absorption of a potentially fatal dose of morphine.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Symptoms of overdose may include slow breathing, slow heartbeat, coma.
No, alcohol can increase the risk of serious side effects such as severe drowsiness/dizziness, severe stomach/abdominal pain, very slow breathing, and unconsciousness.
Common side effects may include drowsiness, dizziness, constipation, and sweating. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
